pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
68
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
tulisokibart
Systemic Sclerosis (Scleroderma)
$MRK
Merck & Co., Inc.
1
catalysts
Phase 2
(ensifentrine + glycopyrrolate)
Chronic Obstructive Pulmonary Disease (COPD)
Verona Pharma Ltd
0
catalysts
Phase 2
AON-D21
Community Acquired Pneumonia
Aptarion Biotech AG
0
catalysts
Phase 2
APPA-02
← prev
page 1 of 3
next →
131
Pain
89
Neurology
1
Resistant Pseudomonas aeruginosa Infections
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 2
ARCT-032
Cystic Fibrosis
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
0
catalysts
Phase 2
AZD-0292
Bronchiectasis
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
0
catalysts
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
0
catalysts
Phase 2
Broncho-Vaxom
Wheezing
OM Pharma Ltd
0
catalysts
Phase 2
CAL-02
Community-Acquired Bacterial Pneumonia
Eagle Pharmaceuticals Inc
0
catalysts
Phase 2
CAL-101
Idiopathic Pulmonary Fibrosis
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Calluna Pharma AS
0
catalysts
Phase 2
CHF-6333
Bronchiectasis
Chiesi Farmaceutici SpA
0
catalysts
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
0
catalysts
Phase 2
CX-1739
Central Sleep Apnea
Glutamate receptor ionotropic AMPA
EndeavourRx LLC
0
catalysts
Phase 2
ETD-001
Cystic Fibrosis
Enterprise Therapeutics Ltd
0
catalysts
Phase 2
INNA-051
Viral Respiratory Tract Infection
ENA Respiratory Pty Ltd
0
catalysts
Phase 2
JadiCell ARDS
Acute Respiratory Distress Syndrome
Breathe Biologics Inc
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Phase 2
LTI-03
Idiopathic Pulmonary Fibrosis
$RNTX
Rein Therapeutics, Inc.
0
catalysts
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
0
catalysts
Phase 2
MesenCure
Acute Respiratory Distress Syndrome
Bonus BioGroup Ltd
0
catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0
catalysts
Phase 2
PF-07872412
Streptococcal Pneumonia
$PFE
PFIZER INC
0
catalysts
Phase 2
Panaecin
Panaecintm (gallium citrate)
Chronic Lung Infection
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
Pneumostem
Bronchopulmonary Dysplasia
MediPost Co Ltd
0
catalysts
Phase 2
RCT-2100
Cystic Fibrosis
Recode Therapeutics Inc
0
catalysts
Phase 2
SASS-001
Obstructive Sleep Apnea
Shionogi-Apnimed Sleep Science LLC
0
catalysts
Phase 2
SION-719
Cystic Fibrosis
$SION
Sionna Therapeutics, Inc.
0
catalysts
Phase 2
SP-101
Cystic Fibrosis
Spirovant Sciences Inc
0
catalysts
